Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
TSPC Stock Overview
PT Tempo Scan Pacific Tbk engages in the pharmaceuticals, personal care and cosmetics, and distribution services businesses in Indonesia and internationally.
Tempo Scan Pacific Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | Rp1,445.00 |
52 Week High | Rp1,790.00 |
52 Week Low | Rp1,420.00 |
Beta | 0.64 |
1 Month Change | -1.70% |
3 Month Change | -4.93% |
1 Year Change | -2.69% |
3 Year Change | -9.40% |
5 Year Change | -29.51% |
Change since IPO | 201.04% |
Recent News & Updates
Shareholder Returns
TSPC | ID Pharmaceuticals | ID Market | |
---|---|---|---|
7D | -1.4% | 1.7% | 3.1% |
1Y | -2.7% | 0.5% | 18.2% |
Return vs Industry: TSPC underperformed the ID Pharmaceuticals industry which returned 0.5% over the past year.
Return vs Market: TSPC underperformed the ID Market which returned 18.2% over the past year.
Price Volatility
TSPC volatility | |
---|---|
TSPC Average Weekly Movement | 1.1% |
Pharmaceuticals Industry Average Movement | 3.7% |
Market Average Movement | 6.2% |
10% most volatile stocks in ID Market | 12.1% |
10% least volatile stocks in ID Market | 3.0% |
Stable Share Price: TSPC is less volatile than 75% of ID stocks over the past 3 months, typically moving +/- 1% a week.
Volatility Over Time: TSPC's weekly volatility (1%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1970 | 4,725 | I Made Wijaya | https://www.temposcangroup.com |
PT Tempo Scan Pacific Tbk engages in the pharmaceuticals, personal care and cosmetics, and distribution services businesses in Indonesia and internationally. The company operates through three segments: Pharmaceuticals, Consumer Products and Cosmetics, and Distribution Services. It is involved in the pharmaceutical and medical devices trading; manufacture of soaps, herbal products, powder milk, food and beverages, and plastic packaging; and manufacturing and trading of consumer products, cosmetics, and household products.
Tempo Scan Pacific Fundamentals Summary
TSPC fundamental statistics | |
---|---|
Market Cap | Rp6.52t |
Earnings (TTM) | Rp823.77b |
Revenue (TTM) | Rp11.23t |
7.9x
P/E Ratio0.6x
P/S RatioIs TSPC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
TSPC income statement (TTM) | |
---|---|
Revenue | Rp11.23t |
Cost of Revenue | Rp7.26t |
Gross Profit | Rp3.98t |
Other Expenses | Rp3.16t |
Earnings | Rp823.77b |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
n/a
Earnings per share (EPS) | 182.66 |
Gross Margin | 35.42% |
Net Profit Margin | 7.33% |
Debt/Equity Ratio | 11.6% |
How did TSPC perform over the long term?
See historical performance and comparisonDividends
2.8%
Current Dividend Yield44%
Payout RatioValuation
Is Tempo Scan Pacific undervalued compared to its fair value and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PEG Ratio
PB vs Industry
7.91x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: TSPC (IDR1445) is trading above our estimate of fair value (IDR816.99)
Significantly Below Fair Value: TSPC is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: TSPC is good value based on its PE Ratio (7.9x) compared to the ID Pharmaceuticals industry average (20.7x).
PE vs Market: TSPC is good value based on its PE Ratio (7.9x) compared to the ID market (18.5x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate TSPC's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: TSPC is good value based on its PB Ratio (1x) compared to the ID Pharmaceuticals industry average (2.5x).
Future Growth
How is Tempo Scan Pacific forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score
0/6Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
15.7%
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Tempo Scan Pacific has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Past Performance
How has Tempo Scan Pacific performed over the past 5 years?
Past Performance Score
3/6Past Performance Score 3/6
Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE
10.5%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: TSPC has high quality earnings.
Growing Profit Margin: TSPC's current net profit margins (7.3%) are higher than last year (7.2%).
Past Earnings Growth Analysis
Earnings Trend: TSPC's earnings have grown by 10.5% per year over the past 5 years.
Accelerating Growth: TSPC's earnings growth over the past year (4.6%) is below its 5-year average (10.5% per year).
Earnings vs Industry: TSPC earnings growth over the past year (4.6%) underperformed the Pharmaceuticals industry 11.7%.
Return on Equity
High ROE: TSPC's Return on Equity (12.8%) is considered low.
Financial Health
How is Tempo Scan Pacific's financial position?
Financial Health Score
5/6Financial Health Score 5/6
Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage
Financial Position Analysis
Short Term Liabilities: TSPC's short term assets (IDR6,239.0B) exceed its short term liabilities (IDR1,895.3B).
Long Term Liabilities: TSPC's short term assets (IDR6,239.0B) exceed its long term liabilities (IDR873.8B).
Debt to Equity History and Analysis
Debt Level: TSPC has more cash than its total debt.
Reducing Debt: TSPC's debt to equity ratio has increased from 3.6% to 11.6% over the past 5 years.
Debt Coverage: TSPC's debt is well covered by operating cash flow (86.7%).
Interest Coverage: TSPC earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Dividend
What is Tempo Scan Pacific current dividend yield, its reliability and sustainability?
Dividend Score
2/6Dividend Score 2/6
Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage
2.77%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: TSPC's dividend (2.77%) is higher than the bottom 25% of dividend payers in the ID market (1.13%).
High Dividend: TSPC's dividend (2.77%) is low compared to the top 25% of dividend payers in the ID market (4.15%).
Stability and Growth of Payments
Stable Dividend: TSPC's dividend payments have been volatile in the past 10 years.
Growing Dividend: TSPC's dividend payments have fallen over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (43.7%), TSPC's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (59.4%), TSPC's dividend payments are covered by cash flows.
Discover strong dividend paying companies
Management
How experienced are the management team and are they aligned to shareholders interests?
4.9yrs
Average management tenure
CEO
I Made Wijaya (51 yo)
1.33yrs
Tenure
Mr. I Made Dharma Wijaya had been President Director of PT Tempo Scan Pacific Tbk since 2021 and has been its Director of PT Tempo Scan Pacific Tbk since 2018 and serves as its Managing Director of Sales &...
Leadership Team
Experienced Management: TSPC's management team is considered experienced (4.9 years average tenure).
Board Members
Experienced Board: TSPC's board of directors are considered experienced (5.8 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
PT Tempo Scan Pacific Tbk's employee growth, exchange listings and data sources
Key Information
- Name: PT Tempo Scan Pacific Tbk
- Ticker: TSPC
- Exchange: IDX
- Founded: 1970
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Implied Market Cap: Rp6.517t
- Shares outstanding: 4.51b
- Website: https://www.temposcangroup.com
Number of Employees
Location
- PT Tempo Scan Pacific Tbk
- Tempo Scan Tower
- 16th Floor
- Jakarta
- Jakarta Raya
- 12950
- Indonesia
Listings
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2022/05/21 00:00 |
End of Day Share Price | 2022/05/20 00:00 |
Earnings | 2021/12/31 |
Annual Earnings | 2021/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.